SG cancer diagnostics firm Clearbridge BioMedics raises $4.8m ahead of IPO

Photo: Bloomberg

Clearbridge BioMedics, a Singapore-based medical technology and cancer diagnostics firm, has raised S$6.6 million ($4.8 million) in funding ahead of a planned initial public offering (IPO).

In a statement on its website, Clearbridge said the pre-IPO funding was backed by oncology medical professionals and investors focused in healthcare and biotechnology.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter